These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 19251638)
1. Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Lobsiger CS; Boillee S; McAlonis-Downes M; Khan AM; Feltri ML; Yamanaka K; Cleveland DW Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4465-70. PubMed ID: 19251638 [TBL] [Abstract][Full Text] [Related]
2. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice. Turner BJ; Ackerley S; Davies KE; Talbot K Hum Mol Genet; 2010 Mar; 19(5):815-24. PubMed ID: 20008901 [TBL] [Abstract][Full Text] [Related]
3. Progressive Degeneration and Inhibition of Peripheral Nerve Regeneration in the SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis. Deng B; Lv W; Duan W; Liu Y; Li Z; Ma Y; Zhang G; Song X; Cui C; Qi X; Li Y; Li C Cell Physiol Biochem; 2018; 46(6):2358-2372. PubMed ID: 29742495 [TBL] [Abstract][Full Text] [Related]
4. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261 [TBL] [Abstract][Full Text] [Related]
5. The accumulation of enzymatically inactive cuproenzymes is a CNS-specific phenomenon of the SOD1 Hilton JB; Kysenius K; White AR; Crouch PJ Exp Neurol; 2018 Sep; 307():118-128. PubMed ID: 29906423 [TBL] [Abstract][Full Text] [Related]
6. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Shibata N Neuropathology; 2001 Mar; 21(1):82-92. PubMed ID: 11304046 [TBL] [Abstract][Full Text] [Related]
7. Selective knockdown of mutant SOD1 in Schwann cells ameliorates disease in G85R mutant SOD1 transgenic mice. Wang L; Pytel P; Feltri ML; Wrabetz L; Roos RP Neurobiol Dis; 2012 Oct; 48(1):52-7. PubMed ID: 22668777 [TBL] [Abstract][Full Text] [Related]
8. The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis. D'Ambrosi N; Finocchi P; Apolloni S; Cozzolino M; Ferri A; Padovano V; Pietrini G; Carrì MT; Volonté C J Immunol; 2009 Oct; 183(7):4648-56. PubMed ID: 19734218 [TBL] [Abstract][Full Text] [Related]
9. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487 [TBL] [Abstract][Full Text] [Related]
10. Immunodetection of disease-associated conformers of mutant cu/zn superoxide dismutase 1 selectively expressed in degenerating neurons in amyotrophic lateral sclerosis. Sábado J; Casanovas A; Hernández S; Piedrafita L; Hereu M; Esquerda JE J Neuropathol Exp Neurol; 2013 Jul; 72(7):646-61. PubMed ID: 23771221 [TBL] [Abstract][Full Text] [Related]
11. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells. Oh YK; Shin KS; Yuan J; Kang SJ J Neurochem; 2008 Feb; 104(4):993-1005. PubMed ID: 18233996 [TBL] [Abstract][Full Text] [Related]
12. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555 [TBL] [Abstract][Full Text] [Related]
13. Prolonged survival and milder impairment of motor function in the SOD1 ALS mouse model devoid of fibroblast growth factor 2. Thau N; Jungnickel J; Knippenberg S; Ratzka A; Dengler R; Petri S; Grothe C Neurobiol Dis; 2012 Aug; 47(2):248-57. PubMed ID: 22542539 [TBL] [Abstract][Full Text] [Related]
14. The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis. Wang L; Sharma K; Grisotti G; Roos RP Neurobiol Dis; 2009 Aug; 35(2):234-40. PubMed ID: 19442735 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS. Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077 [TBL] [Abstract][Full Text] [Related]
16. Tissue-engineered in vitro modeling of the impact of Schwann cells in amyotrophic lateral sclerosis. Louit A; Beaudet MJ; Gros-Louis F; Berthod F Biotechnol Bioeng; 2022 Jul; 119(7):1938-1948. PubMed ID: 35289393 [TBL] [Abstract][Full Text] [Related]
17. Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex. Zhang F; Ström AL; Fukada K; Lee S; Hayward LJ; Zhu H J Biol Chem; 2007 Jun; 282(22):16691-9. PubMed ID: 17403682 [TBL] [Abstract][Full Text] [Related]